CinCor Pharma, Inc. Increase (Decrease) in Accrued Liabilities
CinCor Pharma, Inc. reported Increase (Decrease) in Accrued Liabilities of -$2.96 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2022-11-03
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-09-30 was -$2.41M.
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-06-30 was $2.77M, a 24.57% increase year-over-year.
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-03-31 was -$3.32M.
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was $3.48M.
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was $4.03M, a 251.21% increase from fiscal 2020.
- CinCor Pharma, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was $1.15M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $358.69K derived: sum of 2 quarters · filed 2022-11-03 | -$2.96M 10-Q · filed 2022-11-03 | $521.29K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$552.36K 10-Q · filed 2022-08-08 | $2.93M derived: sum of 3 quarters · filed 2022-08-08 | $2.29M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$3.32M 10-Q · filed 2022-05-10 | $162.60K derived: sum of 2 quarters · filed 2022-05-10 | -$472.54K derived: sum of 3 quarters · filed 2022-11-03 | $1.75M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $2.85M derived: sum of 2 quarters · filed 2022-11-03 | $5.07M derived: sum of 3 quarters · filed 2022-11-03 | $4.03M 10-K · filed 2022-03-22 |
| 2021-09-30 | -$635.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.58M derived: sum of 2 quarters · filed 2022-11-03 | $546.32K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.18M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$1.04M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.15M 10-K · filed 2022-03-22 |